Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Joint research project will evaluate ABS-103 for the treatment of epilepsy

Aug. 13, 1998

Sepracor patents single-isomer form of zopiclone for treatment of sleep disorders

Aug. 13, 1998

French team discovers ciproxifan, a histaminergic agent with clinical potential in AD

Aug. 12, 1998

ADIR discovers new compounds with affinity for imidazoline receptors

Aug. 12, 1998

Searle withdraws support for development of CCD-3693; CoCensys will forge ahead

Aug. 11, 1998

Studies with spheron-targeted AD treatment candidate yield promising results

Aug. 11, 1998

MABE: a new enkephalin analogue with analgesic potential

Aug. 11, 1998

New CNS agents described by French team

Aug. 11, 1998

4030W92 antihyperalgesic effect due to preferential action on slow activation state of Na+ channel

Aug. 11, 1998

Japanese investigators study antinociceptive dynorphin analogue

Aug. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...